publication date: Dec. 9, 2010

In this issue: 

FDA Orders More Changes In ESA Label,

Agents Not Indicated In Curative Setting.

In NEJM Letter, Henschke Acknowledges Error In 2006 I-ELCAP Paper; Critics Call For Audit.

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

Download (PDF 1.0MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.